JBDI
JBDI Holdings Ltd
$0.6890
-3.09%
$13.1M
No data for this timeframe.
Vol
Market Cap$13.1M
Cap SizeNano Cap
SEC Reports2
Exchange Nasdaq·Sector Metal Shipping Barrels, Drums, Kegs & Pails·Inc. E9·CIK 0001964314·Prev Close $0.7110
Recent Activity
May 29, 2026
SEC
JBDI Holdings Ltd held its Annual General Meeting on May 28, 2026, where shareholders approved a 1-for-2 reverse stock s
6-K — Impact 4/10
May 21, 2026
SEC
JBDI Holdings filed a 6-K with proxy materials for its Annual General Meeting on May 28, 2026, seeking shareholder appro
6-K — Impact 3/10
Latest Reports
NEUTRAL
6-K
4/10
JBDI Holdings Ltd held its Annual General Meeting on May 28, 2026, where shareholders approved a 1-for-2 reverse stock s
May 29, 2026
NEUTRAL
6-K
3/10
JBDI Holdings filed a 6-K with proxy materials for its Annual General Meeting on May 28, 2026, seeking shareholder appro
May 21, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 3.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.